⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14526300 | 0.72 | — | — | |
| SCHEMBL11888134 | 0.70 | — | — | |
| SCHEMBL14828375 | 0.70 | — | — | |
| SCHEMBL11997234 | 0.62 | — | — | |
| SCHEMBL13939658 | 0.58 | — | — | |
| SCHEMBL14290264 | 0.58 | — | — | |
| Ethylene SCHEMBL8300809 | 0.57 | MAPK1 (0.32) | — | |
| SCHEMBL13652409 | 0.57 | — | — | |
| Hydrochloric Acid SCHEMBL15561523 | 0.55 | — | — | |
| SCHEMBL12446829 | 0.55 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023221994-A1 | MILK PROTEIN COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 上海昌进生物科技有限公司 | 2023-11-23 | — | — | WO | disclosed |
| US-7858648-B2 | Nanotube complexes are water soluble, nontoxic; use in delivering biologicals such as DNA for gene therapy, DNA vaccines; amine salts derived from diethylenetriaminepentaacetic acid-modified nanotubes with anion such as DNA | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (C.N.R.S.) (FR) | 2010-12-28 | — | — | US | disclosed |
| US-20080076816-A1 | Nanotube complexes are water soluble, nontoxic; use in delivering biologicals such as DNA for gene therapy, DNA vaccines; amine salts derived from diethylenetriaminepentaacetic acid-modified nanotubes with anion such as DNA | THE UNIVERSITY OF MANCHESTER (GB) | 2008-03-27 | — | — | US | disclosed |
| EP-1754060-A2 | NON-COVALENT COMPLEXES COMPRISING CARBON NANOTUBES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) | 2007-02-21 | — | — | EP | disclosed |
| WO-2005121799-A2 | NON-COVALENT COMPLEXES COMPRISING CARBON NANOTUBES | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2005-12-22 | — | — | WO | disclosed |
| US-5587295-A | CHOLESTEROL TEST PERFORMED ON SKIN | 2860601 CANADA INC. (CA) | 1996-12-24 | — | — | US | disclosed |
| US-5489510-A | COMPLEXING OF CHOLESTEROL WITH ENZYMATIC AGENT AND INDICATOR | 2860601 CANADA INC. (CA) | 1996-02-06 | — | — | US | disclosed |
| US-5356781-A | Zymogen activation peptides (ZAP) in the diagnosis of disease | BIOSCIENCE INTERNATIONAL, INC. (US) | 1994-10-18 | — | — | US | disclosed |
| EP-0258995-B1 | Diagnosis, severity prediction, and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens | BIOSCIENCE INT INC (US) | 1994-04-13 | — | — | EP | disclosed |
| US-4948723-A | ASSAYING BODY FLUIDS FOR ACTIVATION PEPTIDES OF PANCREATIV ZYMOGENS CLEAVED BY PROTEOLYSIS | BIOSCIENCE INTERNATIONAL, INC. (US) | 1990-08-14 | — | — | US | disclosed |
| EP-0258995-A1 | Diagnosis, severity prediction, and monitoring of disease by immunoassay of free activation peptides of pancreatic zymogens | BIOSCIENCE INTERNATIONAL, INC. (US) | 1988-03-09 | — | — | EP | disclosed |
| WO-1988001059-A1 | DIAGNOSIS OF PANCREATIC DISEASE | BIOSCIENCE INTERNATIONAL INC. (US) | 1988-02-11 | — | — | WO | disclosed |